Lin Charles Y 4
4 · Kronos Bio, Inc. · Filed Feb 23, 2024
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Lin Charles Y
SR VP, RESEARCH & DEVELOPMENT
Transactions
- Sale
Common Stock
2024-02-21$1.05/sh−12,036$12,685→ 234,603 total
Footnotes (2)
- [F1]Represents shares sold to satisfy estimated tax withholding obligations upon the settlement of restricted stock units.
- [F2]The weighted average sale price for the transaction reported was $1.0539, and the range of prices were between $1.02 to $1.11. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.